Brief: Oncolytics Biotech Reports 2021 First Quarter Financial Results
07/05/2021 12:12
May 7 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® REPORTS 2021 FIRST QUARTER DEVELOPMENT
HIGHLIGHTS AND FINANCIAL RESULTS
* Q1 LOSS PER SHARE C$0.13
* AS OF MARCH 31, 2021, CO REPORTED $50.4 MILLION IN CASH
AND CASH
EQUIVALENTS
* Q1 EARNINGS PER SHARE VIEW C$-0.17 -- REFINITIV IBES DATA
Source text for Eikon: ID:nCNW9R2Nfa
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer